Breaking News
Upgrade 0
📈 💰 Our AI knew ViaSat had strong potential… now it's up +99.7%
Pick Stocks with AI
Close

Perpetuum Vita Spezial R (0P00001CPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.340 -0.020    -0.05%
29/08 - Closed. Currency in EUR
Type:  Fund
Market:  Luxembourg
ISIN:  LU0225963817 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 6.08M
Perpetuum Vita Spezial R 39.340 -0.020 -0.05%

0P00001CPR Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Perpetuum Vita Spezial R (0P00001CPR) fund. Our Perpetuum Vita Spezial R portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 17.920 18.000 0.080
Shares 71.580 73.970 2.390
Bonds 10.480 10.480 0.000
Other 0.020 0.020 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 15.040 16.847
Price to Book 1.868 2.484
Price to Sales 1.244 1.872
Price to Cash Flow 7.315 10.038
Dividend Yield 3.440 2.452
5 Years Earnings Growth 7.357 11.007

Sector Allocation

Name  Net % Category Average
Industrials 20.340 12.839
Financial Services 18.790 16.249
Consumer Defensive 12.480 7.144
Utilities 11.880 3.366
Technology 8.580 19.596
Healthcare 8.310 11.162
Basic Materials 6.340 7.122
Communication Services 4.200 7.633
Real Estate 3.910 2.650
Consumer Cyclical 3.110 11.735
Energy 2.060 4.851

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Developed Markets

Top Holdings

Number of long holdings: 49

Number of short holdings: 3

Name ISIN Weight % Last Change %
IP Global Strategy Y LU3060240861 5.58 - -
  European Union 3 04-Mar-2053 EU000A3K4DY4 4.52 82.600 -0.39%
IP Global Strategy X LU1626623844 3.30 - -
  E.ON SE DE000ENAG999 3.09 15.245 -1.65%
  Siemens AG DE0007236101 3.07 236.60 -0.11%
  Deutsche Telekom AG DE0005557508 3.07 31.220 -0.51%
Nordrhein-Westfalen (Land) DE000NRW0MP9 3.01 - -
  Schneider Electric FR0000121972 2.83 210.05 -1.71%
  SAP DE0007164600 2.76 231.700 -1.97%
  Air Liquide FR0000120073 2.45 176.22 -0.67%

Top Equity Funds by Fund Development and Advisory AG

  Name Rating Total Assets YTD% 3Y% 10Y%
  FCP MEDICAL BioHealth-Trends EUR 620.92M -7.05 5.24 6.04
  FCP MEDICAL BioHealth Trends I 620.92M -6.78 5.77 6.87
  FCP MEDICAL BioHealth Trends I H 620.92M 1.44 6.68 5.22
  FCP MEDICAL BioHealth Trends EUR H 620.92M 0.45 6.23 4.39
  FFPB MultiTrend Plus 227.62M 2.86 4.78 1.98
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00001CPR Comments

Write your thoughts about Perpetuum Vita Spezial R
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email